-
Celltrion, Inc. (Korean: 주식회사 셀트리온) is a
biopharmaceutical company headquartered in Incheon,
South Korea.
Celltrion Healthcare conducts worldwide marketing...
- Remsima) were
submitted for
approval in the
European Union, by
Hospira and
Celltrion Healthcare respectively. Both had a
positive opinion from
European Medicines...
-
School following the
expiration of her contract. On May 10, Park
joined Celltrion Entertainment. On July 3 it was
announced that Park had
changed her promotional...
-
Celltrion Entertainment Co., Ltd. (formerly
known as
Dream E&M Co., Ltd.) is a
South Korean production and
artist management company under the Celltrion...
-
directed against the
spike protein of SARS-CoV-2. It is
developed by
Celltrion. The
medicine is
given by
infusion (drip) into a vein. The most common...
- Brzoska, CEO,
InPost Group (Poland); and
JungJin SEO,
Honorary Chairman,
Celltrion Group (South Korea). Periodically,
global leaders are
bestowed awards...
-
prescription drugs marketed in the Asia-Pacific
region to
South Korea's
Celltrion in a deal
worth $278 million. Also in 2020,
Takeda sold
TachoSil to Corza...
-
Yuhan is one of the top
Korean pharmaceutical companies,
along with
Celltrion,
Samsung Biologics, GC Pharma, and
Hanmi Pharmaceutical. Yuhan-Kimberly...
- lapsed, a
number of
biosimilars such as Hadlima, Hyrimoz, Cyltezo, and
Celltrion were
launched in the US. In
February 2024, adalimumab-ryvk (Simlandi)...
-
Cederroth (1895– ) Cel-Sci (1983– )
Celesio (1835– )
Celgene (1986– )
Celltrion (2002– )
Cencora (2001– )
Century (1966– )
Ceragenix (????– ) Cerevel...
